Flashback Foreword: Gemcitabine/Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Transitional Cell Carcinoma

J Clin Oncol. 2023 Aug 10;41(23):3879-3880. doi: 10.1200/JCO.23.00286.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Transitional Cell* / drug therapy
  • Carcinoma, Transitional Cell* / pathology
  • Cisplatin / therapeutic use
  • Deoxycytidine / therapeutic use
  • Doxorubicin / therapeutic use
  • Gemcitabine
  • Humans
  • Methotrexate / therapeutic use
  • Urinary Bladder Neoplasms* / drug therapy
  • Urinary Bladder Neoplasms* / pathology
  • Vinblastine / therapeutic use

Substances

  • Cisplatin
  • Methotrexate
  • Vinblastine
  • Gemcitabine
  • Deoxycytidine
  • Doxorubicin